Beranda › Kardiomiopati › Michigan
Uji klinis Kardiomiopati di Michigan
7 studi untuk Kardiomiopati mencari peserta di lokasi di Michigan.
Kota di Michigan
Teks studi resmi (Bahasa Inggris)
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Detroit
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07052903Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Henry Ford Health System, Detroit
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06563895Danon Disease Natural History Study
- University of Michigan, Ann Arbor
Menerima pesertaStudi observasional
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT06214507The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
- Henry Ford Health, Detroit
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT05034432MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- University of Michigan, Ann Arbor
Menerima pesertaFase 3
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 27 Mar 2026 · NCT06128629Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
- Henry Ford Health System, Detroit
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2025 · NCT06964464A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM
- University of Michigan, Ann Arbor
- Henry Ford Hospital, Detroit
Menerima pesertaStudi observasional
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 16 Mei 2025 · NCT06976606Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.